Please add info@sitcancer.org to your safe senders list.
February 2016 – In this Issue
Society Updates | New Fellowship Opportunity | Education & Events | Membership
Publications & Resources | Careers
A Message from the President
Dear Colleagues,
We’re only a few months into 2016 and it’s already shaping up to be a monumental year—not only for the field of cancer immunotherapy but also for SITC as we prepare to embark on a number of new initiatives and educational activities throughout the year.
As the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy, we work hard to ensure all of our members—students, clinicians, scientists, industry professionals and government representatives alike—have access to and are engaged in the implementation of timely, cutting-edge translational clinical research in cancer immunotherapy. Whether you’re a student or an established professional in the field, there are opportunities to advance personally and professionally at SITC. Learn more about SITC membership and how you can help shape the success of the Society in 2016 here.
With more activities scheduled in 2016 than ever before there’s no reason 2016 shouldn’t be yet another record-breaking year!
Best regards,
Howard L. Kaufman, MD, FACS
SITC President
Society Updates
SITC Cancer Immunotherapy Fellowship Submission Period Ending Soon!
In concert with the Society’s mission to improve cancer patient outcomes through the development and application of cancer immunotherapy, SITC is presenting to SITC student members several one-year fellowship opportunities, which were made possible through the generosity of AstraZeneca, EMD Serono, and Genentech. Applications will be accepted through Monday, March 7, 2016. Learn more and apply here.
New Opportunity!
Announcing the 2016 NCI Cancer Immunotherapy Fellowship
Co-sponsored
by the National Cancer Institute and the Society for Immunotherapy of
Cancer and made possible in part by an educational grant from
EMD-Serono.
The
Society for Immunotherapy of Cancer (SITC) is proud to announce the
launch of the National Cancer Institute (NCI) Cancer Immunotherapy
Fellowship. This award, co-sponsored by the NCI Center for Cancer
Research and SITC and made possible in part by an educational grant from
EMD-Serono, will provide a young investigator with an opportunity to
further their education and experience in the field of cancer
immunotherapy.
This training program is designed for physicians who have completed a
medical oncology fellowship program in the United States and who seek
specialized training in immunotherapy with clinical trials and clinical
trial development. The 1-year program, at the CCR in Bethesda, Maryland,
allows the fellow to have exposure to multiple clinical
immunotherapeutic approaches, and also to key opinion leaders in the
field of clinical immunotherapy. This fellowship provides opportunities
to understand how to design, write, and run clinical trials, how to
treat patients, how to manage toxicities, as well as opportunities to
work with multiple experimental agents.
Get more information, including eligibility requirements, here. Applications for the NCI Cancer Immunotherapy Fellowship will be accepted through March 21, 2016.
Education & Events
Immunotherapy Biomarkers 2016: Overcoming the Barriers
Cosponsored with the National Cancer Institute
Friday, April 1, 2016 • 8 a.m. – 5 p.m.
National Institutes of Health Campus • Bethesda, Maryland
"Cancer immunotherapy biomarkers are an area of critical need in the field," states SITC Vice President and SITC Immune Biomarkers Task Force Chair, Lisa H. Butterfield, PhD. "They provide insight into mechanism of action, and can help predict who should be enrolled into clinical trials, or at least who is likely to benefit. At this meeting, the SITC Immune Biomarkers Task Force Working Groups will present their summaries of the state of the field, identify hurdles, highlight new opportunities and make recommendations, all in a one day program."
Learn more and register here.
Cancer Immunotherapy 101 in Milwaukee, Wisconsin
Register Early for Best Rates!
Thursday, April 7, 2016 • 5 p.m. – 8:45 p.m.
Hilton Milwaukee City Center
Part of the Advances in Cancer ImmunotherapyTM series, this introductory, CME- and CE-certified program will provide clinical oncologists, nurses, pharmacists, and the entire team involved in treating cancer patients with a greater understanding of cancer immunotherapies, their therapeutic effectiveness, and the appropriate selection and management of patients.
Learn more and register here by March 17, 2016 at 5 p.m. ET for discounted early registration rates.
Can't make it to Milwaukee? More dates and locations are available!
Save the Dates for SITC 2016 – November 9-13, 2016
Gaylord National Hotel & Convention Center • National Harbor, Maryland
Mark your calendars for SITC's 31st
Annual Meeting & Associated Programs! Known as the premier
destination for scientific exchange, education and networking in the
cancer immunotherapy field, this is the conference you don't want to miss. Learn more.
31st Annual Meeting Highlights
Keynote Speakers
Ira Mellman, PhD – Genentech
Suzanne L. Topalian, MD – Johns Hopkins University, 2016 Richard V. Smalley, MD Memorial Award Keynote Address
Featured Annual Meeting Topics
- Adoptive Cellular Therapy vs. Bispecific Antibodies
- Clinical Management (part of the Nurse/Pharmacist track)
- Combination Immunotherapy
- Diet, Exercise, Stress and the Impact on the Immune System
- Emerging Technologies
- Inflammation, Innate Immunity and Microbiome
- Metabolism: Dendritic cells, T cells, Aging, Tumors
- Promoting and Measuring Anti-Tumor Immunity
- Tumor Immunology 101 (part of the Nurse/Pharmacist track)
- Tumor Microenvironment
- Value of Cancer Immunotherapy
Membership Makes a Difference
Do You Love Being a Part of SITC? Connect-a-Colleague!
New
members often join SITC because a current member has invited them.
Please encourage your colleagues, including nurses, pharmacists, and
students, to become official SITC members by sending personalized
invitations with our online tool. If each SITC member recruits two others, we could quickly grow to 3,000 members!
Membership benefits include:
- Discounted registration rates on all SITC programs
- Eligibility to apply for SITC fellowships and grants, available exclusively to SITC members
- Free access to SITC "Members Only" section, including meeting slides and other online resources
- Free access to SITC's online member directory
- Waived article processing charges (a $2,500 USD savings) for SITC’s open access journal, the Journal for ImmunoTherapy of Cancer (JITC)
- ... and much more!
Top referrers will receive recognition for their efforts. To connect a colleague, log in to your member profile here!
Not a member yet? Join today!
SITC is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy. As a member, you will join a growing network of nearly 1,300 basic and translational scientists, practitioners, healthcare professionals, government leaders, and industry professionals worldwide.
There are several membership categories including: Regular, Affiliate, Allied Health, Emeritus, Nurse and Physician Extender, Patient and Patient Advocate, Pharmacist, and Scientist-in-Training/Student memberships. To learn more about these categories, and to apply, visit the Membership page.
Already a Member? Don't Forget to Renew!
Renew your membership here or call our office at +1 414-271-2456.
Publications & Resources
Journal for ImmunoTherapy of Cancer, the Resource for Cutting-Edge Science in the Field
Journal for ImmunoTherapy of Cancer
(JITC) is SITC's official open access, peer-reviewed journal. It
encompasses all aspects of tumor immunology and cancer immunotherapy,
from basic research to clinical application. As the global voice of the
Society, JITC is the resource for SITC publications and also serves as a
targeted outlet for publication of original research articles,
literature reviews and position papers.
Additionally, JITC features monthly technology primers produced by the SITC Immune Biomarkers Task Force. A hot topic in the field, these papers examine the latest in biomarker technologies for cancer immunotherapy. Access the articles here, and join us in Bethesda, Maryland on April 1 for Immunotherapy Biomarkers 2016: Overcoming the Barriers.
Interested in publishing in JITC? SITC members receive waived article processing charges for papers accepted through 2016. Submit your manuscript here.
Latest Career Opportunities from SITC's Job Board
Senior Scientist Immunology (PhD)
DCPrime - Netherlands
Senior Scientist Immuno-Oncology (PhD)
DCPrime - Netherlands
Senior Technician
DCPrime - Netherlands
Vice President, Clinical Development
Biopharmaceutical Company - Bay Area
If you are interested in posting an open position to SITC's job board, please reference this agreement form for posting criteria or contact SITC at info@sitcancer.org.
ADVERTISEMENT
Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org
© 2016 Society for Immunotherapy of Cancer
Join us on:
If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.
Please add info@sitcancer.org to your safe senders list.